Skip Navigation



Carcinogenesis Advance Access published online on October 29, 2005
Carcinogenesis, doi:10.1093/carcin/bgi252
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
27/3/610    most recent
bgi252v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Millikan, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Millikan, R. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org
Received July 12, 2005
Revised October 19, 2005
Accepted October 26, 2005

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma study

Robert C. Millikan 1*, Amanda Hummer 2, Colin Begg 2, Jon Player 1, Allan René de Cotret 1, Scott Winkel 1, Harvey Mohreweiser 3, Nancy Thomas 1, Bruce Armstrong 4, Anne Kricker 4, Loraine D. Marrett 5, Stephen B. Gruber 6, Hoda Anton Culver 3, Roberto Zanetti 7, Richard P. Gallagher 8, Terence Dwyer 9, Timothy Rebbeck 10, Klaus Busam 2, Lynn From 11, Urvi Mujumdar 2, Marianne Berwick 12, and for the GEM Study Group

1 University of North Carolina, Chapel Hill, NC
2 Memorial Sloan-Kettering Cancer Center, New York, NY
3 University of California, Irvine, CA
4 University of Sydney, Sydney, New South Wales, Australia
5 Cancercare Ontario, Toronto, Ontario, Canada
6 University of Michigan, Ann Arbor, MI
7 Centro per la Prevenzione Oncologia, Torino, Piemonte, Italy
8 British Columbia Cancer Agency, Vancouver, BC, Canada
9 Royal Children's Hospital, Parkville, Victoria, Australia
10 University of Pennsylvania, Philadelphia, PA
11 Women's College Hospital, Toronto, Ontario, Canada
12 University of New Mexico, Albuquerque, NM

* To whom correspondence should be addressed.
Robert C. Millikan, E-mail: millikan{at}email.unc.edu


  Abstract

Polymorphisms in six genes involved in nucleotide excision repair of DNA were examined in a large, population-based case-control study of melanoma. Genotyping was conducted for 2485 patients with a single primary melanoma (controls) and 1238 patients with second or higher order primary melanomas (cases). Patients were ascertained from nine geographic regions in Australia, Canada, Italy and the United States. Positive associations were observed for XPD 312 Asn/Asn versus Asp/Asp [Odds ratio (OR) = 1.5, 95% Confidence Interval (CI) 1.2-1.9)] and XPD 751 Gln/Gln versus Lys/Lys (OR = 1.4, 95% CI 1.1-1.7) genotypes and melanoma. The combined XPD Asn (A) 312 + Gln (C) 751 haplotype was significantly more frequent in cases (32%) compared with controls (29%) (P = 0.003) and risk of melanoma increased significantly with one and two copies of the haplotype (ORs 1.2, 95% CI 1.0-1.4, and 1.6, 95% CI 1.2-2.0, trend P = 0.002). No significant associations were observed for HR23B codon 249, XPG codon 1104, XPC codon 939, XPF codon 415, XPF nt 2063, ERCC6 codon 1213 or ERCC6 codon 1230. Odds ratios for XPD and XPC genotypes were stronger for melanoma diagnosed at an early age, but tests for interaction were not statistically significant. The results provide further evidence for a role of XPD in the etiology of melanoma.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. R. McWilliams, W. R. Bamlet, M. de Andrade, D. N. Rider, J. M. Cunningham, and G. M. Petersen
Nucleotide Excision Repair Pathway Polymorphisms and Pancreatic Cancer Risk: Evidence for role of MMS19L
Cancer Epidemiol. Biomarkers Prev., April 1, 2009; 18(4): 1295 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. R. McWilliams, W. R. Bamlet, J. M. Cunningham, E. L. Goode, M. de Andrade, L. A. Boardman, and G. M. Petersen
Polymorphisms in DNA Repair Genes, Smoking, and Pancreatic Adenocarcinoma Risk
Cancer Res., June 15, 2008; 68(12): 4928 - 4935.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Yang, J. Gu, X. Lin, H. B. Grossman, Y. Ye, C. P. Dinney, and X. Wu
Profiling of Genetic Variations in Inflammation Pathway Genes in Relation to Bladder Cancer Predisposition
Clin. Cancer Res., April 1, 2008; 14(7): 2236 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
W. Wang, M. R. Spitz, H. Yang, C. Lu, D. J. Stewart, and X. Wu
Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer
Clin. Cancer Res., October 1, 2007; 13(19): 5974 - 5981.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. An, Z. Liu, Z. Hu, G. Li, L.-E Wang, E. M. Sturgis, A. K. El-Naggar, M. R. Spitz, and Q. Wei
Potentially Functional Single Nucleotide Polymorphisms in the Core Nucleotide Excision Repair Genes and Risk of Squamous Cell Carcinoma of the Head and Neck
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1633 - 1638.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. E. Thomas, S. N. Edmiston, A. Alexander, R. C. Millikan, P. A. Groben, H. Hao, D. Tolbert, M. Berwick, K. Busam, C. B. Begg, et al.
Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 991 - 997.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. E. Povey, F. Darakhshan, K. Robertson, Y. Bisset, M. Mekky, J. Rees, V. Doherty, G. Kavanagh, N. Anderson, H. Campbell, et al.
DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma
Carcinogenesis, May 1, 2007; 28(5): 1087 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
C. Li, Z. Hu, Z. Liu, L.-E Wang, S. S. Strom, J. E. Gershenwald, J. E. Lee, M. I. Ross, P. F. Mansfield, J. N. Cormier, et al.
Polymorphisms in the DNA Repair Genes XPC, XPD, and XPG and Risk of Cutaneous Melanoma: a Case-Control Analysis
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2526 - 2532.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. A. Kanetsky, T. R. Rebbeck, A. J. Hummer, S. Panossian, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. A. Culver, et al.
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Cancer Res., September 15, 2006; 66(18): 9330 - 9337.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Berwick, I. Orlow, A. J. Hummer, B. K. Armstrong, A. Kricker, L. D. Marrett, R. C. Millikan, S. B. Gruber, H. Anton-Culver, R. Zanetti, et al.
The Prevalence of CDKN2A Germ-Line Mutations and Relative Risk for Cutaneous Malignant Melanoma: An International Population-Based Study.
Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1520 - 1525.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.